Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 1,841 shares, an increase of 34.1% from the December 15th total of 1,373 shares. Based on an average daily volume of 34,654 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 34,654 shares, the days-to-cover ratio is currently 0.1 days.

Revolution Medicines Trading Down 9.6%

RVMDW traded down $0.33 during mid-day trading on Friday, hitting $3.09. The stock had a trading volume of 596,226 shares, compared to its average volume of 355,684. The stock’s fifty day simple moving average is $1.10 and its 200-day simple moving average is $0.56. Revolution Medicines has a 1-year low of $0.03 and a 1-year high of $3.59.

About Revolution Medicines

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.